Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Tingting MA, Jie WU, Lijie Y, Fen F, Huilin Y, Jinhua Z, et al
Understanding which patients are candidates for GLP-1RAs treatment will be key, according to Lorenzo Leggio, MD, PhD, clinical director of the National Institute on Drug Abuse
Ferrario CR, Reagan LP
Which Works Better for a Natural Glow
Exendin-4, a Glucagonlike Peptide-1 Receptor Agonist, Attenuates Breast Cancer Growth by Inhibiting NF-b Activation
US$ 20.38
US$ 20.31
US$ 27.31
US$ 26.69
US$ 22.72
US$ 23.71
US$ 29.73
US$ 25.37
